Clinical Summary
Clinical Summary: Generative Artificial Intelligence in Mental Health: A Guide for Primary Care Providers
Patients are already using generative artificial intelligence chatbots for emotional support, coping, and mental health advice, often outside clinical oversight. For primary care providers managing anxiety and depression, the practical challenge is to recognize where these tools may help as adjuncts, where they fail in complex or high-risk situations, and how to counsel patients about safety, privacy, and overreliance.
Presentation
Worsening anxiety and depressive symptoms while relying on an “AI chatbot” for daily support
Patient
27-year-old woman with generalized anxiety disorder and allergic rhinitis on citalopram 10 mg/day
Key Question
How should PCPs evaluate and counsel patients using generative AI mental health tools?
Red Flags
Family history notable for obsessive-compulsive disorder, major depressive disorder, and maternal suicide; rising GAD-7 and PHQ-9 scores
Clinical Approach
- Differential Diagnosis: When a patient reports benefit from a generative AI chatbot, clinicians should distinguish adjunctive coping support from problematic substitution for professional care or human connection, especially if the chatbot is reinforcing rumination, dependence, or isolation.
- Differential Diagnosis: Complex or high-risk psychiatric presentations require special caution because generative AI may miss nuance and provide inappropriate advice in settings such as psychosis, mania, thoughts of suicide or homicide, severe substance use, or postpartum risk states.
- Evaluation: Assess what the patient is using the tool for, such as CBT, motivational interviewing, monitoring, emotional support, symptom tracking, or advice, and how interactive and personalized the platform is.
- Evaluation: Review the evidence supporting the specific tool’s intended use and clarify whether it is being used as an adjunct to care rather than as a substitute for professional mental health treatment.
- Evaluation: Evaluate safety, privacy, and data governance by determining where and how the app stores data, whether data are encrypted, whether personal data may be used to train models, and which legal jurisdictions oversee data processing.
- Evaluation: For suicide assessment, validated tools such as the Columbia Suicide Severity Rating Scale remain foundational; NLP- and machine learning-based approaches may serve as adjuncts to capture dynamic risk signals between visits but require real-world validation and careful integration.
- Management: Counsel patients to use generative AI tools as adjuncts for self-management, symptom monitoring, and homework between sessions, and avoid recommending them as substitutes for care when there is significant risk of harm or a need for crisis management.
- Management: Discuss disadvantages directly, including lack of contextual understanding, factual errors, inability to manage crises, privacy concerns, algorithmic bias, and the risk that chatbots may mirror rather than challenge distorted thoughts.
- Management: Document these discussions in the medical record and, when possible, steer patients toward programs that comply with local standards or have been independently evaluated without industry biases.
- Management: In the case vignette, after reviewing the chatbot’s benefits and limitations, the patient agreed to increase her citalopram dosage and began looking in earnest for a CBT-proficient psychotherapist.
Clinical Bottom Line
Generative AI mental health tools may help some patients with short-term support, but they should be treated as adjuncts, not replacements for professional care. Primary care providers should actively assess how patients are using these tools, screen for dependence and safety risks, and counsel about privacy, bias, and crisis limitations.
Practice Implications
- Ask directly whether a patient is using a chatbot for emotional support, coping advice, symptom monitoring, or therapy-like interactions, and determine whether use is replacing human care or relationships.
- Do not rely on generative AI chatbots for crisis evaluation; if suicide risk, psychosis, mania, severe substance use, or homicidal thoughts are present, use clinician-led assessment and crisis management.
- When patients want to try a tool, review whether there is peer-reviewed evidence for the specific function it claims to provide and explain that benefit data are variable and often limited in durability.
- Make privacy counseling routine: advise patients to avoid entering sensitive personal health information into direct-to-consumer chatbots and review transparency around consent, storage, sharing, and deletion of data.
